Premature ovarian failure, also known as primary ovarian insufficiency (POI), affects 1% of all women worldwide. In most cases, the exact cause of the condition, which is often associated with infertility, is difficult to determine. A new study by researchers from Tel Aviv University and Schneider Children’s Medical Center throws a spotlight on a previously-unidentified cause of POI, a unique mutation in a gene called SYCE1 that has not been previously associated with POI in humans.
While the genes involved in chromosome duplication and division had been shown to cause POI in animal models, this is the first time a similar mutation has been identified in humans.
The team state that it is known that POI may be associated with Turner’s syndrome, a condition in which a woman has only one X chromosome instead of two, or could be due to toxins like chemotherapy and radiation therapy. However, in 90% of the cases, the exact cause remains a mystery.
The opportunity for a genetically-based study came when the team were asked to treat two POI patients, daughters of two sets of Israeli-Arab parents who were related to each other. The girls presented with typical POI symptoms, one patient had the appearance of puberty but had not gotten her period, and the other one had not started puberty at all. After ruling out the usual suspects (toxins, autoimmune disease, and known chromosomal and genetic diseases), the researchers set out to identify the genetic cause of POI in the two young women.
The team explain that the clinical presentation of the two sisters, out of 11 children of first-degree cousins, was interesting. In each of the girls, POI was expressed differently. One had reached puberty and was almost fully developed but didn’t have menses. The second, 16 years old, showed no signs of development whatsoever.
The researchers performed genotyping in the patients, their parents, and siblings. For this, DNA from the affected sisters was subjected to whole-exome sequencing. Genotyping was also performed in 90 ethnically matched control individuals.
The genotyping revealed a mutation that results in nonfunctional protein product in the SYCE1 gene in both affected sisters. The parents and three brothers were found to be carriers of the mutation, and an unaffected sister did not carry the mutation.
By identifying the genetic mutation the researchers presented evidence that any chance of inducing fertility in these two girls is slight. The team state that this will allow the girls, once they are old enough, to avoid certain fertility treatments and instead invest efforts in acquiring an egg donation. Knowledge is half the battle, and now the entire family knows it should undergo genetic testing for this mutation.
The researchers are currently investigating evidence of the effects of this genetic mutation on male members of the family, but state that this is not always easy in traditional societies and that here is still a lot to be done on this subject.
Michelle is a health industry veteran who taught and worked in the field before training as a science journalist.
Featured by numerous prestigious brands and publishers, she specializes in clinical trial innovation--expertise she gained while working in multiple positions within the private sector, the NHS, and Oxford University.